Search
for
Sort by
Research 61–90 of 1000+
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Dermatologic manifestations of endocrine disorders
- Finasteride Treatment of Patterned Hair Loss in Normoandrogenic Postmenopausal Women
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Dermatology of androgen-related disorders
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Nonclassic Congenital Adrenal Hyperplasia
- 5α-Reduced glucocorticoids: a story of natural selection
- Acquired hypertrichosis lanuginosa: Case report and review of the literature
- Testosterone therapy in women: Myths and misconceptions
- Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Nonclassic congenital adrenal hyperplasia
- Polycystic ovarian syndrome
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Is polycystic ovary syndrome a sexual conflict? A review
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Congenital adrenal hyperplasia
- An intergenerational androgenic mechanism of female intrasexual competition in the cooperatively breeding meerkat
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- Women’s Health Considerations for Lipid Management
- Androgenetic Alopecia
- Chapter 23. Therapeutic Control of Androgen Action
- Polycystic ovary syndrome: Challenges in adolescence
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- Women’s Health Considerations for Lipid Management
- Steroid Hormones
- Acne in children
- Clinical use of 5α-reductase inhibitors